Table 2: The results of the measurements show the mean values and the standard deviation (SD), the 95% confidential interval (CI) of the control group (CG), and the individual values of the patient. P-values were obtained from paired T-test. Values of the patient which fall outside the 95% CI of the CG are marked with an asterisk (*). Values of the patient falling out of the entire range of variation of the CG in pre- and post-test are marked with a double-dagger (‡). For the CG, N = 10, except for CD4+ and CD8+ in the pre-test with N = 8 each. The reference values for the shown CDs are 55-83% (CD 3), 28-57% (CD 4), 10-39% (CD 8), 7-31% (CD 16/56).
Lymphocytes | CD3+ | CD4+ | |||||||
pre | post | p-value | pre | post | p-value | pre | post | p-value | |
Mean ± SDCG | 30.8 ± 9.1 | 29.7 ± 6.5 | 0.73 | 68.0 ± 14.9 | 73.4 ± 6.1 | 0.32 | 44.6 ± 10.7 | 47.5 ± 6.3 | 0.15 |
95% CICG | 24.3-37.3 | 25.0-34.4 | 57.3-78.7 | 69.1-77.7 | 35.7-53.5 | 43.0-52.0 | |||
Total rangeCG | 20.1-52.3 | 17.1-40.1 | 29.3-81.3 | 60.8-80.6 | 31.5-62.5 | 36.4-59.9 | |||
Patient | 18.8* | 27.2 | 62.4 | 79.0* | 37.9 | 53.4* | |||
CD8+ | CD16+/CD56+ | CD19+ | |||||||
pre | post | p-value | pre | post | p-value | pre | post | p-value | |
Mean ± SDCG | 25.9 ± 6.4 | 23.9 ± 4.1 | 0.23 | 11.1 ± 6.1 | 7.4 ± 2.0 | 0.10 | 11.7 ± 6.2 | 12.7 ± 3.7 | 0.64 |
95% CICG | 20.6-31.2 | 21.0-26.9 | 6.8-15.4 | 6.0-8.9 | 7.3-16.1 | 10.0-15.3 | |||
Total rangeCG | 18.1-35.3 | 19.6-30.1 | 4.3-19.9 | 4.4-11.6 | 1.2-20.5 | 7.6-19.5 | |||
Patient | 22.4 | 23.8 | 2.9*‡ | 3.9*‡ | 23.7*‡ | 12.9 |